IGF-1_LR3 is a research peptide used in preclinical laboratory models involving metabolic, mitochondrial, immune, or regenerative pathways.

What is it?

IGF-1 LR3 is a synthetic analog of insulin-like growth factor 1 developed for investigational and in vitro research use. It incorporates structural modifications, including an extended amino acid sequence and reduced binding affinity to IGF-binding proteins, which are intended to prolong molecular activity and stability in experimental settings.

In preclinical and laboratory research models, IGF-1 LR3 has been examined for its interaction with IGF-1 receptor signaling pathways involved in cellular growth, proliferation, and nutrient-related anabolic signaling. These characteristics have made it a compound of interest in experimental studies exploring muscle cell biology, tissue growth signaling, and metabolic adaptation mechanisms.

MECHANISM OF INTEREST

Pathway	Description
Angiogenesis	Observed to influence vascular endothelial pathways.
Tissue Repair	Supports modeling of gastric, tendon, and muscular healing.
Cytoprotection	Evaluated for protective effects in oxidative environments.

KEY RESEARCH APPLICATIONS

- Tissue repair and regeneration research

- Inflammation pathway modeling

- Angiogenesis studies

HANDLING & STORAGE

Lyophilized: Store at –20°C, protect from light and moisture.

Reconstituted: Store at 2–8°C, avoid freeze–thaw cycles.

RESEARCH USE ONLY

This product is supplied strictly for laboratory, research, and development use. Not for human consumption or therapeutic application.